Zheng, K.; Gao, Y.; Xu, J.; Kang, M.; Chai, R.; Jin, G.; Kang, Y.
mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin. Biomedicines 2025, 13, 1.
https://doi.org/10.3390/biomedicines13010001
AMA Style
Zheng K, Gao Y, Xu J, Kang M, Chai R, Jin G, Kang Y.
mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin. Biomedicines. 2025; 13(1):1.
https://doi.org/10.3390/biomedicines13010001
Chicago/Turabian Style
Zheng, Kewei, Yi Gao, Jing Xu, Mingyi Kang, Ranran Chai, Guanqin Jin, and Yu Kang.
2025. "mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin" Biomedicines 13, no. 1: 1.
https://doi.org/10.3390/biomedicines13010001
APA Style
Zheng, K., Gao, Y., Xu, J., Kang, M., Chai, R., Jin, G., & Kang, Y.
(2025). mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin. Biomedicines, 13(1), 1.
https://doi.org/10.3390/biomedicines13010001